+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Allergy Diagnostic and Treatment Market 2019-2027

  • ID: 4773801
  • Report
  • June 2019
  • Region: Global
  • 145 pages
  • Triton Market Research
1 of 4

FEATURED COMPANIES

  • Allergan plc
  • Beckman Coulter
  • Glaxosmithkline, plc
  • Johnson & Johnson
  • Merck
  • Mylan N.V.
  • MORE
Market Outlook
As per the author, it is anticipated that the global allergy diagnostic and treatment market will make a progressive growth by exhibiting a CAGR of 5.27% during the forecast period of 2019-2027.

The increasing pervasiveness of target diseases due to air pollution (for example, asthma) and food allergies supported by the sedentary and dietary way of lifestyles across the globe are the key factors that are driving the growth of the global allergy diagnostic and treatment market. Moreover, the rising urbanization in developing nations, growing environmental pollution, increasing concentrations of ozone-harming substances in the air, rising healthcare expenditures, expanding interests of IVD tests for the treatment of allergic diseases and improvement of cutting-edge determination technology are boosting the allergy diagnostic and treatment market across the globe. However, factors such as stringent government regulations on the usage of medical devices, high cost of treatment and lack of awareness are hampering the growth of the global allergy diagnostic and treatment market.

The global allergy diagnostic and treatment market is segmented based on immunotherapy, diagnostics and treatments. Based on immunotherapy, the market is bifurcated into sublingual tablets, sublingual liquid solutions and subcutaneous administration. The diagnostics segment is classified into antibody and skin testing.

Regional Outlook
The global allergy diagnosis and treatment market has been studied based on the geographies that contribute significantly to the development of the market. The geographical segment is classified into Asia-Pacific, North America, Europe, Latin America and the Middle East & Africa. North America is estimated to be the major contributor in the global allergy diagnosis and treatment market, primarily due to the expanding pervasiveness of allergic diseases in the region. The growing awareness about allergy diagnostics such as in-vitro blood tests and the rising instances of allergic respiratory peculiarities are driving the North America market.

Europe relies upon a high growth rate of its developed pharmaceuticals industry and the surging interest for therapeutics. Other driving factors include rising cases of allergic conditions and the fast-expanding geriatric population. On the other hand, the growing pharmaceuticals market in Asia and the rising demands from developing nations like China and India are driving the development of the Asian market.

Competitive Outlook
The key players in the global allergy diagnostic and treatment market are Hitachi Chemical Diagnostics, Inc., Allergan PLC, Johnson & Johnson, Mylan N.V., F. Hoffmann-La Roche, Ltd, Merck, Pfizer, Sanofi, Beckman Coulter, GlaxoSmithKline PLC and Thermo Fisher Diagnostics.

Merck is a multinational research-driven pharmaceutical giant based in New Jersey, USA. The company is known for developing and marketing vaccines and drugs for a variety of conditions. Merck’s best-selling respiratory product Singulair lost patent protection in the US and Europe in 2012 and 2013, respectively, and will lose protection in Japan in 2016. The company markets immunotherapy products named Grastek and Ragwitek in the US for ALK-Abelló.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan plc
  • Beckman Coulter
  • Glaxosmithkline, plc
  • Johnson & Johnson
  • Merck
  • Mylan N.V.
  • MORE
1. Allergy Diagnostic And Treatment Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitute
2.2.3. Bargaining Power Of Buyers
2.2.4. Bargaining Power Of Suppliers
2.2.5. Threat Of Rivalry
2.3. Vendor Scorecard
2.4. Patent Outlook
2.5. Key Buying Outlook
2.6. Key Insights
2.7. Supply Chain Outlook
2.8. Market Drivers
2.8.1. Increasing Air Pollution
2.8.2. Rise In Tobacco Consumption
2.8.3. Increase In The Prevalence Of Allergic Diseases
2.9. Market Restraints
2.9.1. Probable Side-Effects Of Drugs Is The Restraining Factor
2.9.2. Stringent Regulations
2.9.3. Capital Requirements Is High For The R&D Of Diagnostic And Treatments Tools
2.9.4. Dearth Of Cognizance Among The People About Allergies
2.10. Market Opportunities
2.10.1. Upsurge In Awareness About Allergic Diseases
2.10.2. High Growth Opportunities In Developing Economies
2.11. Market Challenges
2.11.1. Expiry Of Major Drugs In The Offing
2.11.2. Accessibility Of Generic Drugs In The Market
2.11.3. Availability Of Alternate Treatments
2.11.4. Swelling Healthcare Expenditure

3. Allergy Diagnostic And Treatment Market Outlook - By Immunotherapy, Diagnostic And Treatments
3.1. Immunotherapy
3.1.1. Sublingual Liquid Solutions
3.1.2. Subcutaneous Administration
3.1.3. Sublingual Tablets
3.2. Diagnostics
3.2.1. Antibody
3.2.2. Skin Testing
3.3. Treatments
3.3.1. Treatment Market By Availability
3.3.1.1. Prescription
3.3.1.2. Over The Counter
3.3.2. Treatment Market By Administration
3.3.2.1. Topical
3.3.2.2. Spray
3.3.2.3. Oral
3.3.2.4. Ocular
3.3.3. Treatment Market By Products
3.3.3.1. Antihistamines
3.3.3.2. Mast Cell Stabilizers
3.3.3.3. Corticosteroids
3.3.3.4. Leukotrienes
3.3.3.5. Sympathomimetics, Decongestants And Combinations

4. Allergy Diagnostic And Treatment Market - Regional Outlook
4.1. North America
4.1.1. Country Analysis
4.1.1.1. The United States
4.1.1.2. Canada
4.2. Europe
4.2.1. Country Analysis
4.2.1.1. Germany
4.2.1.2. France
4.2.1.3. The Uk
4.2.1.4. Russia
4.2.1.5. Italy
4.2.1.6. Spain
4.2.1.7. Rest Of Europe
4.3. Asia-Pacific
4.3.1. Country Analysis
4.3.1.1. India
4.3.1.2. China
4.3.1.3. Japan
4.3.1.4. Australia & New Zealand
4.3.1.5. South Korea
4.3.1.6. ASEAN Countries
4.3.1.7. Rest Of Apac
4.4. Middle East And Africa
4.4.1. Country Analysis
4.4.1.1. United Arab Emirates
4.4.1.2. Turkey
4.4.1.3. Saudi Arabia
4.4.1.4. South Africa
4.4.1.5. Rest Of Middle East And Africa
4.5. Latin America
4.5.1. Country Analysis
4.5.1.1. Brazil
4.5.1.2. Mexico
4.5.1.3. Rest Of Latin America

5. Competitive Landscape
5.1. Glaxosmithkline, plc
5.2. Mylan N.V.
5.3. Hitachi Chemical Diagnostics, Inc.
5.4. Johnson & Johnson
5.5. F. Hoffmann-La Roche, Ltd.
5.6. Beckman Coulter
5.7. Merck
5.8. Pfizer
5.9. Sanofi
5.10. Allergan plc
5.11. Thermo Fisher Diagnostics

6. Research Scope And Methodology
6.1. Research Scope
6.2. Sources Of Data
6.3. Research Methodology

List of Tables
Table 1: Global Allergy Diagnostic And Treatment Market By Geography 2019-2027 ($ Million)
Table 2: Global Allergy Diagnostic And Treatment Market By Treatments, Diagnostics And Immunotherapy 2019-2027 ($ Million)
Table 3: Global Allergy Diagnostic And Treatment Market In Immunotherapy 2019-2027 ($ Million)
Table 4: Global Allergy Diagnostic And Treatment Market In Diagnostics 2019-2027 ($ Million)
Table 5: Global Allergy Diagnostic And Treatment Market In Treatments, By Availability, 2019-2027 ($ Million)
Table 6: Global Allergy Diagnostic And Treatment Market In Treatments, By Administration, 2019-2027 ($ Million)
Table 7: Global Allergy Diagnostic And Treatment Market In Treatments, By Products, 2019-2027 ($ Million)
Table 8: North America Allergy Diagnostic And Treatment Market, By Country, 2019-2027 ($ Million)
Table 9: Europe Allergy Diagnostic And Treatment Market, By Country, 2019-2027 ($ Million)
Table 10: Asia-Pacific Allergy Diagnostic And Treatment Market, By Country, 2019-2027 ($ Million)
Table 11: Middle East And Africa Allergy Diagnostic And Treatment Market, By Country, 2019-2027 ($ Million)
Table 12: Latin America Allergy Diagnostic And Treatment Market, By Country, 2019-2027 ($ Million)

Figures List
Figure 1: Global Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 2: Key Buying Criteria Of Allergy Diagnostic And Treatment Market
Figure 3: Global Treatments Market In Sublingual Liquid Solutions 2019-2027 ($ Million)
Figure 4: Global Treatments Market In Subcutaneous Administration 2019-2027 ($ Million)
Figure 5: Global Treatments Market In Sublingual Tablets 2019-2027 ($ Million)
Figure 6: Global Treatments Market In Antibody 2019-2027 ($ Million)
Figure 7: Global Diagnostics Market In Skin Testing 2019-2027 ($ Million)
Figure 8: Global Treatments Market In Prescription 2019-2027 ($ Million)
Figure 9: Global Treatments Market In Over The Counter 2019-2027 ($ Million)
Figure 10: Global Treatments Market In Topical 2019-2027 ($ Million)
Figure 11: Global Treatments Market In Spray 2019-2027 ($ Million)
Figure 12: Global Treatments Market In Oral 2019-2027 ($ Million)
Figure 13: Global Treatments Market In Ocular 2019-2027 ($ Million)
Figure 14: Global Treatments Market In Antihistamines 2019-2027 ($ Million)
Figure 15: Global Treatments Market In Mast Cell Stabilizers 2019-2027 ($ Million)
Figure 16: Global Treatments Market In Corticosteroids 2019-2027 ($ Million)
Figure 17: Global Treatments Market In Leukotrienes 2019-2027 ($ Million)
Figure 18: Global Treatments Market In Sympathomimetics, Decongestants And Combinations 2019-2027 ($ Million)
Figure 19: The United States Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 20: Canada Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 21: Percentage Of People Suffering From Severe Food Allergy In Canada 2017
Figure 22: Germany Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 23: France Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 24: The United Kingdom Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 25: Russia Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 26: Italy Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 27: Spain Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 28: Rest Of Europe Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 29: India Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 30: China Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 31: Japan Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 32: Australia & New Zealand Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 33: South Korea Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 34: ASEAN Countries Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 35: Rest Of Apac Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 36: The Uae Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 37: Turkey Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 38: Saudi Arabia Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 39: South Africa Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 40: Rest Of Middle East And Africa Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 41: Brazil Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 42: Mexico Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Figure 43: Rest Of Latin America Allergy Diagnostic And Treatment Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4
  • Glaxosmithkline, plc
  • Mylan N.V.
  • Hitachi Chemical Diagnostics, Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche, Ltd.
  • Beckman Coulter
  • Merck
  • Pfizer
  • Sanofi
  • Allergan plc
  • Thermo Fisher Diagnostics
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll